LTG-001 for Acute Pain After Abdominoplasty

This clinical trial is designed to find out if a medication called LTG-001 can effectively manage pain after undergoing an abdominoplasty, commonly known as a tummy tuck. The study focuses on people who have just had this type of surgery and aims to understand how well the drug can control pain within the first 48 hours after the operation. It also seeks to determine the most effective dose of LTG-001 and assess its safety during this period. This study is important because managing pain effectively after surgery can significantly improve recovery and comfort for patients. Participants in this study will take the medication LTG-001 twice a day after their abdominoplasty. They will stay in the clinic for about 48 hours while the medication is administered, allowing researchers to closely monitor their response to the treatment. After two weeks, participants will return for a safety check-up. During the initial 48-hour period, they will report any changes in their pain levels, helping to evaluate how well LTG-001 alleviates post-operative pain. The study will gather data on both the effectiveness and tolerability of the medication, contributing valuable information for future pain management strategies.